References
- Gunseren F, Mamikoglu L, Ozturk S, et al. A surveil-lance study of antimicrobial resistance of Gram-negative bacte-ria isolated from intensive care units in eight hospitals in Turkey. J Antimicrob Chemother 1999; 43: 373–8.
- Aksaray S, Dokuzoguz B, Guvener E, et al. Surveillance of antimicrobial resistance among Gram-negative bacteria iso-lates from intensive care units in eight hospitals in Turkey. J Antimicrob Chemother 2000, 45: 695–99.
- National Committee for Clinical Laboratory Methods. Methods for dilution antimicrobial susceptibility test for bacte-ria that grow aerobically. Third edition: Approved Standard M-7A3. NCCLS, Villanova, PA, 1993.
- Livermore DM, Yuan M. Antibiotic resistance and pro-duction of extended-spectrum I3-lactamases amongst Klebsiella spp. from intensive care units in Europe. J Antimicrob Chemother 1996; 38: 409–24
- Gutmann L, Kitzis MD, Billot-Klein D, et al. Plasmid mediated I3-lactamase (TEM-7) involved in resistance to cef-tazidime and aztreonam. Rev Infect Dis 1988; 10: 860–6.
- Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe: results of the European Prevalence of Infection in Intensive Care (EPIC) Study. JAMA 1995; 274: 639–44.
- Itokazu GS, Quinn JP, Bell-Dixon C, Kahan FM, Weinstein RA. Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance pro-gram. Clin Infect Dis 1996; 23 (4): 779–84.
- Livermore DM. I3-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995; 8: 557–84.
- Jones RN, Pfaller MA, Doern CV, Ervin ME, Hollis RJ. Antimicrobial activity and spectrum invastigation of eight broad spectrum beta-lactam drugs: a 1997 surveillance trial in 102 medical centers in the United states. Cefepime Study Group. Diagn Microbiol Infect Dis 1998; 30 (3): 215–28.
- Sader HS, Jones RN, Gales AC, et al. Antimicrobial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumo-nia: analysis of results from the SENTRY Antimicrobial Surveillance Program (1997). SENTRY Latin America Study Group. Diagn Microbiol Infect Dis 1998; 32 (4): 289–301.
- Shah PM, Manger R, Kahan FM. Incidence of multi-resistance in gram-negative aerobes from intensive care units of 10 German hospitals. Scand J Infect Dis 1991; Suppl 78: 22-34.
- Vahaboglu H, Hall LMC, Mtilazimoglu L, Dodanli S, Yildinm I, Livermore DM. Resistance to extended-spectrum cephalosporins, caused by PER-1 beta-lactamase in Salmonella typhimurium from Istanbul, Turkey. J Med Microbiol 1995; 43: 294–9.
- Danel F, Hall LMC, Gar D, Akalin HE, Livermore DM. Transferable production of PER-1 I3-lactamase in Pseudo-monas aeruginosa. J Antimicrob Chemother 1995; 35: 281–94.
- Vahaboglu H, Ozturk R, Aygun G, et al. Widespread detection of PER-1-type extended-spectrum beta-lactamases among nosocomial Acinetobacter and Pseudomonas aerugi-nosa isolates in Turkey: a nationwide multicenter study. Antimicrob Agents Chemother 1997; 41 (10): 2265–9.
- Yucesoy M, Yulug N, Kocagoz S, Unal S, Cetin S, Calangu S. Antimicrobial resistance of Gram-negative isolates from intensive care units in Turkey: comparison to previous three years. J Chemother 2000; 12 (4): 294–8.